Directorio de personas
Xavier Matias-Guiu Guia

Xavier Matias-Guiu Guia

Grado: Doctor/a

973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/C-3039-2009

Publicaciones

  • Gras, E; Catasus, L; Arguelles, R; Moreno-Bueno, G; Palacios, J; Gamallo, C; Matias-Guiu, X; Prat, J

    Microsatellite instability, MLH-1 promoter hypermethylation, and frameshift mutations at coding mononucleotide repeat microsatellites in ovarian tumors

    CANCER 92 2829-2836. .

    [doi:10.1002/1097-0142(20011201)92:11<2829::AID-CNCR10094>3.0.CO;2-3]

  • Matias-Guiu, X; Prat, J

    Tumor invasion and metastasis - Nature or nurture? Reply

    HUMAN PATHOLOGY 32 1416-1416. .

    [doi:10.1053/hupa.2001.29637]

  • Domingo, P; Matias-Guiu, X; Pujol, RM; Domingo, JC; Arroyo, JA; Sambeat, MA; Vazquez, G

    Switching to nevirapine decreases insulin levels but does not improve subcutaneous adipocyte apoptosis in patients with highly active antiretroviral therapy-associated lipodystrophy

    JOURNAL OF INFECTIOUS DISEASES 184 1197-1201. .

    [doi:10.1086/323805]

  • Rodriguez, I; Ayala, E; Caballero, C; De Miguel, C; Matias-Guiu, X; Cubilla, AL; Rosai, J

    Solitary fibrous tumor of the thyroid gland - Report of seven cases

    AMERICAN JOURNAL OF SURGICAL PATHOLOGY 25 1424-1428. .

    [doi:10.1097/00000478-200111000-00011]

  • Gras, E; Pons, C; Machin, P; Matias-Guiu, X; Prat, J

    Loss of heterozygosity at the RB-1 locus and pRB immunostaining in epithelial ovarian tumors: a molecular, immunohistochemical, and clinicopathologic study

    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY 20 335-340. .

    [doi:10.1097/00004347-200110000-00004]

  • Gras, E; Cortes, J; Diez, O; Alonso, C; Matias-Guiu, X; Baiget, M; Prat, J

    Loss of heterozygosity on chromosome 13q12-q14, BRCa-2 mutations and lack of BRCa-2 promoter hypermethylation in sporadic epithelial ovarian tumors

    CANCER 92 787-795. .

    [doi:10.1002/1097-0142(20010815)92:4<787::AID-CNCR1384>3.0.CO;2-4]

  • Rocha, AS; Soares, P; Seruca, R; Maximo, V; Matias-Guiu, X; Cameselle-Teijeiro, J; Sobrinho-Simoes, M

    Abnormalities of the E-cadherin/catenin adhesion complex in classical papillary thyroid carcinoma and in its diffuse sclerosing variant

    JOURNAL OF PATHOLOGY 194 358-366. .

    [doi:10.1002/path.905]

  • Matias-Guiu, X; Catasus, L; Bussaglia, E; Lagarda, H; Garcia, A; Pons, C; Munoz, J; Arguelles, R; Machin, P; Prat, J

    Molecular pathology of endometrial hyperplasia and carcinoma

    HUMAN PATHOLOGY 32 569-577. .

    [doi:10.1053/hupa.2001.25929]

  • Palacios, J; Catasus, L; Moreno-Bueno, G; Matias-Guiu, X; Prat, J; Gamallo, C

    beta- and gamma-catenin expression in endometrial carcinoma. Relationship with clinicopathological features and microsatellite instability

    VIRCHOWS ARCHIV 438 464-469. .

    [doi:10.1007/s004280000371]

  • Esteller, M; Cordon-Cardo, C; Corn, PG; Meltzer, SJ; Pohar, KS; Watkins, DN; Capella, G; Peinado, MA; Matias-Guiu, X; Prat, J; Baylin, SB; Herman, JG

    p14(aRF) silencing by promoter hypermethylation mediates abnormal intracellular localization of MDM2

    CANCER RESEARCH 61 2816-2821. .

  • Pujol, RM; Perez-Losada, E; Matias-Guiu, X; Fuentes, J; Alonso, C; Alomar, A; Craven-Bartle, J

    Postirradiation multiple minute digitate porokeratosis

    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY 5 126-130. .

    [doi:10.1007/s102270000012]

  • Perez-Losada, E; Pujol, RM; Domingo, P; Matias-Guiu, X; Lenti, J; Lopez-Pousa, A; Alomar, A

    Hypertrichosis lanuginosa acquisita preceding extraskeletal Ewing's sarcoma

    CLINICAL AND EXPERIMENTAL DERMATOLOGY 26 182-183. .

    [doi:10.1046/j.1365-2230.2001.00791.x]

Proyectos

  • Unravelling the molecular and phenotypic complexity of endometriosis through new models and omics integration: towards a personalized clinical management
  • Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
  • EPH Receptor Signaling in Endometrial Cancer
  • Ajuts per a la contractació de personal investigador novell (FI)
  • Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
  • "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
  • EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
  • Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
  • DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
  • Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
  • VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU